In order to find out if FR-Sema3C does indeed possess potential as a possible candidate drug for the treatment of exudative AMD, we determined if injection of FR-Sema3C/Fc into the vitreal chamber of C57 black mouse eyes can inhibit CNV induced by laser photocoagulation [52]. The gene discussed is SEMA3C; the disease is age-related macular degeneration.